Polygon Health Analytics Research to Be Presented at the 2026 USCAP Annual Meeting

Polygon Health Analytics Research to Be Presented at the 2026 USCAP Annual Meeting

2 min read

San Antonio, TX — March 18, 2026 — Polygon Health Analytics LLC announced today that its research has been accepted for a platform presentation at the USCAP 115th Annual Meeting of the United States and Canadian Academy of Pathology, taking place March 21–26, 2026, in San Antonio, Texas.

The presentation, “From PDF to Precision Medicine: MAGIC Automates Pathology Report Curation and Links to Genomic Data for Squamous Cell Carcinoma Research,” is based on a Small Business Innovation Research (SBIR) Phase I project supported by the National Cancer Institute (NCI).

“This work shows how automated extraction can transform large collections of pathology reports into research‑ready datasets,” said Dr. Lixia Yao, presenting author. “By building tools that help non‑technical users discover relevant signals across large, complex public cancer datasets, we aim to make it easier for physicians and scientists to accelerate discovery and improve patient outcomes.”

The abstract will be presented by Dr. Lixia Yao during the Informatics session on Monday, March 23, 2026, from 9:00 AM to 9:15 AM at the Henry B. González Convention Center in San Antonio.

Background

The National Cancer Institute hosts over 10 petabytes of genomic, transcriptomic, proteomic, imaging, and clinical datasets, including digitized slides and pathology reports in PDF or scanned-image formats. Similar challenges exist across healthcare systems, where vast amounts of valuable data remain disorganized and underutilized, limiting their potential to support research and improve patient care.

Design

To address these challenges, the team developed MAGIC (Multimodal Analysis of Genomics, Imaging, and Clinical Data), an analytics platform that enables pathologists to leverage large-scale datasets for clinical and translational research. MAGIC applies natural language processing (NLP) to extract standardized indicators, such as tumor site, histologic grade, and margin status, from scanned pathology reports.

The platform interface supports cohort building based on clinical or molecular criteria, with export capabilities for downstream analysis. Squamous cell carcinoma (SCC), a common histotype across multiple organ systems, served as a pilot use case.

Results

Using MAGIC, researchers assembled a cohort of 1,390 SCC cases and exported the dataset to cBioPortal for comparative genomic analysis. The NLP pipeline parsed and normalized unstructured pathology reports in PDF format into structured data elements, including demographics, tumor site, grade, stage, margin status, treatment effect, and histologic features such as differentiation, mitotic activity, lymphovascular invasion, and perineural invasion.

These structured data were linked to sequencing datasets encompassing genomic alterations and gene expression profiles stored in the NCI Commons.

As a use case, the team examined associations among tumor grade, primary site, and mutation profiles. A comparison of 754 Grade 1–2 SCC cases with 532 Grade 3–4 cases revealed differences in anatomical site distribution. ZFHX4 mutations were enriched in Grade 3–4 tumors (log₂ ratio = –1.04, p = 3.74×10⁻⁷, q = 6.61×10⁻³), suggesting a potential biomarker associated with tumor aggressiveness.

Conclusions

This proof of concept shows that analyses requiring months of manual curation can be completed in a single day using MAGIC with cBioPortal. By automating pathology report extraction and integrating multi-omic datasets, MAGIC offers an intuitive, scalable, and reproducible tool for translational research.

Contact

For more information, please contact Polygon Health Analytics LLC at info@polygonhealthanalytics.com.

About Polygon Health Analytics LLC

Polygon Health Analytics LLC develops advanced analytics solutions that transform complex healthcare data into actionable insights. The company focuses on real-world data, artificial intelligence, and multimodal data integration to support biomedical research, drug development, and healthcare innovation.

Other Posts You Might Like

PHA LaunchPad Program — Now Recruiting for the 2026 Summer Cohort
PHA LaunchPad Program — Now Recruiting for the 2026 Summer Cohort
Jan 25, 2026
Location: Remote Duration: 3–6 months (part-time or full-time) Start Date: TBA (based on student team availability in the summer) Now entering its third year, the...
Read more
Celebrating 3 Years of Polygon Health Analytics
Celebrating 3 Years of Polygon Health Analytics
Jan 13, 2026
From corporate scientist to health tech founder: a candid three-year journey of building Polygon Health Analytics, transforming data, and redefining leadership....
Read more
Synthetic Data vs. Real-World Data: A Reality Check for Healthcare AI
Synthetic Data vs. Real-World Data: A Reality Check for Healthcare AI
Dec 15, 2025
I first encountered the concept of synthetic data back in 2013, while teaching a health informatics course as a tenure-track assistant professor at UNC Charlotte. To...
Read more
Drug Development Program Done Right: A Practical Checklist to Prevent Strategic Blind Spots
Drug Development Program Done Right: A Practical Checklist to Prevent Strategic Blind Spots
Nov 28, 2025
In the high-stakes world of pharmaceutical R&D, thousands of drug candidates are abandoned every year long before reaching patients. The harsh reality: fewer than...
Read more
QALYs Explained: The Metric That’s Shaping—and Dividing—Healthcare Policy
QALYs Explained: The Metric That’s Shaping—and Dividing—Healthcare Policy
Nov 10, 2025
Quality-Adjusted Life Years (QALYs) are a cornerstone concept in health economics. They measure the value of medical treatments by considering both how long people live and...
Read more
Value-Based Health Care: Shifting the Focus from Quantity to Quality
Value-Based Health Care: Shifting the Focus from Quantity to Quality
Oct 23, 2025
Understand how value-based health care shifts focus from volume to outcomes, rewarding better results, reducing costs and improving patient care....
Read more
Budget Impact Models: A Practical Tool for Healthcare Decision-Making
Budget Impact Models: A Practical Tool for Healthcare Decision-Making
Oct 07, 2025
Learn how Budget Impact Models help payers and HTA agencies assess short-term affordability of new healthcare treatments alongside cost-effectiveness analysis....
Read more
New White Paper: Charting the Landscape of Real-World Data in the U.S.
New White Paper: Charting the Landscape of Real-World Data in the U.S.
Oct 01, 2025
Learn how real-world data is transforming U.S. healthcare and life sciences. Our new white paper maps datasets, applications, challenges, and future directions....
Read more
Chart showing global vaccine trial trends
Polygon Health Analytics Launches Vaccine Trial Atlas: Making Clinical Trial Data Accessible
Sep 16, 2025
The vaccine research and development community has faced unprecedented challenges in recent months, including policy upheavals, leadership changes, research program cancellations, and a surge of misinformation...
Read more
Launchpad
Polygon Health Analytics Celebrates Graduation of 2025 Launchpad Cohort
Sep 03, 2025
[Philadelphia, September 2, 2025] – Polygon Health Analytics proudly announces the successful graduation of its 2025 Launchpad Program cohort—the second since the program’s inception—marking...
Read more
View all